Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Demerol on demand

PreclinicalSmall molecule

SSeoul National University Hospital

Demerol on demand is one of 2 small molecule programs targeting Nephrectomy. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

NephrectomyCompleted

NephrectomyPreclinical

Completed

Competition

Competitive Landscape

1 competitor in Nephrectomy

#DrugCompanyPhaseTrials

Esmeron

FFresenius Kabi USA, LLC

Demerol on demand

SSeoul National University Hospital

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Nephrectomy1 trial

The Intrathecal Morphine for Nephrectomy

Completed·SSeoul National University Hospital·N/A·NCT01997788·46 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Demerol on demand. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Demerol on demand compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Demerol on demand. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SSeoul National University Hospital

Related News